| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |